Lymphedema Terminated Phase 2 Trials for Indocyanine green (DB16024)

Also known as: Lymohedema / Lymphoedema / Lymphoedemas / Lymphoedema NOS

IndicationStatusPhase
DBCOND0029071 (Lymphedema)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01276054Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.Supportive Care